Location History:
- Irvine, CA (US) (1995)
- Ulm, DE (1998)
Company Filing History:
Years Active: 1995-1998
Title: Innovations and Contributions of Inventor Stephan Grissmer
Introduction
Stephan Grissmer is a notable inventor based in Irvine, CA (US). He has made significant contributions to the field of biomedical research, particularly in the area of autoimmune diseases and ion channel expression. With a total of 2 patents, his work has implications for both diagnostics and therapeutic approaches.
Latest Patents
Grissmer's latest patents include innovative methods and products based on n K.sup.+ channel expression. This disclosure relates to the n K.sup.+ channel expression product of the MK3 gene or a functionally bioactive equivalent thereof and its uses, particularly in combination with identifying immune responses and materials modulating or blocking the same. Another significant patent focuses on the assay for and treatment of autoimmune diseases. This disclosure relates to the general diagnosis and treatment of autoimmune diseases with materials identified in assays based upon the finding that such diseases manifest by elevated numbers of type l K.sup.+ channels in abnormal CD4.sup.- CD8.sup.- T cells.
Career Highlights
Grissmer is affiliated with the University of California, where he continues to advance research in his field. His work has garnered attention for its potential to improve the understanding and treatment of autoimmune conditions.
Collaborations
He has collaborated with esteemed colleagues such as Michael D. Cahalan and Kanianthara G. Chandy, contributing to a rich environment of innovation and discovery.
Conclusion
Stephan Grissmer's contributions to the field of biomedical research through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in the diagnosis and treatment of autoimmune diseases.